BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma
<p><strong>Background and Aims</strong></p> The dismal prognosis of pancreatic ductal adenocarcinoma (PDAC) is linked to the presence of pancreatic cancer stem-like cells (CSCs) that respond poorly to current chemotherapy regimens. The epigenetic mechanisms regulating CSCs ar...
Main Authors: | Feng, Y, Cai, L, Pook, M, Liu, F, Chang, C-H, Mouti, MA, Nibhani, R, Militi, S, Dunford, J, Philpott, M, Fan, Y, Fan, G-C, Liu, Q, Qi, J, Wang, C, Hong, W, Morgan, H, Wang, M, Sadayappan, S, Jegga, AG, Oppermann, U, Wang, Y, Huang, W, Jiang, L, Pauklin, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2023
|
Similar Items
-
SMAD2/3-SMYD2 and developmental transcription factors cooperate with cell cycle inhibitors to guide tissue formation
by: Militi, S, et al.
Published: (2024) -
Mechanisms of cancer cell death: Therapeutic implications for pancreatic ductal adenocarcinoma
by: Pook, H, et al.
Published: (2021) -
TGFB1/INHBA homodimer/nodal-SMAD2/3 signaling network: a pivotal molecular target in PDAC treatment
by: Abdel Mouti, M, et al.
Published: (2021) -
Rewiring of 3D chromatin topology orchestrates transcriptional reprogramming and the development of human dilated cardiomyopathy
by: Feng, Y, et al.
Published: (2022) -
RBL2-E2F-GCN5 guide cell fate decisions during tissue specification by regulating cell-cycle-dependent fluctuations of non-cell-autonomous signaling
by: Militi, S, et al.
Published: (2023)